Press Release

Technological advancement in healthcare is accelerating. With each breakthrough, we are seeing more effective and efficient ways to address complex medical challenges. In this context, demand for High-Potency Active Pharmaceutical

December 10, 2025

Escalating Health Issues and API The Active Pharmaceutical Ingredients (API) market is increasing constantly, as it is a crucial active raw material used in medicines to determine their strength, dosage

November 24, 2025

India and China are dominating the API industry globally, driven by several factors, including low labour costs, a highly skilled workforce, strong infrastructure, numerous USFDA/EMA-approved plants, and government-friendly policies. For

November 24, 2025

Desvenlafaxine succinate market strengthens as FDA approvals support broader antidepressant therapy adoption. Industry Overview Desvenlafaxine succinate market is growing at a CAGR of 2.8% during the forecast period (2025-2035). Desvenlafaxine

August 20, 2025

Dr. Reddy’s Laboratories has officially received the Establishment Inspection Report (EIR) from the U.S. Food and Drug Administration (US FDA) for the Active Pharmaceutical Ingredient (API) manufacturing facility in Middleburgh,

August 19, 2025

Increasing infectious disease prevalence, growth of generic formulations, and growing healthcare availability are fueling the Amoxicillin Sodium market. Industry Overview Amoxicillin sodium market is growing at a CAGR of 1.9%

July 9, 2025

Zydus Lifesciences has reached a significant regulatory milestone as the US Food and Drug Administration (FDA) has given a No Action Indicated (NAI) status to its Active Pharmaceutical Ingredient (API)

July 9, 2025

How can we help you?

Reach out to discuss how our team can help your business achieve real results.